Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0001382963-15-000036

President and CEO gave up 46,036 shares (to pay taxes)

  • President and CEO acquired 124,252 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Riccitelli Samuel D · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-06-19 Exercise or conversion : show line 1 in the form +124,252 377,166 D
2015-06-19 Shares withheld for taxes : show line 2 in the form −46,036 $1.51 $69,514 331,130 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2015-06-19 Exercise or conversion : show line 3 in the form Restricted Stock Units −124,252 124,252 248,503 D
Loading xslF345X03/edgar.xml…